# Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis

> **NCT00007995** · PHASE2 · COMPLETED · sponsor: **Herbert Irving Comprehensive Cancer Center** · enrollment: 75 (estimated)

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** recombinant interferon alfa
- **BIOLOGICAL:** sargramostim
- **DRUG:** busulfan
- **DRUG:** cyclophosphamide
- **DRUG:** melphalan
- **PROCEDURE:** autologous bone marrow transplantation
- **PROCEDURE:** bone marrow ablation with stem cell support
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00007995
- **Lead sponsor:** Herbert Irving Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** 2007-11
- **Final completion:** 2008-05
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2013-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00007995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00007995, "Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients Who Have Multiple Myeloma or Primary Systemic Amyloidosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00007995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*